Advertisement

Topics

RegeneRx Biopharmaceuticals Company Profile

22:37 EST 12th December 2018 | BioPortfolio

RegeneRx is a publicly-traded biopharmaceutical company focused on the discovery and development of novel molecules to accelerate tissue and organ repair. Our stock is traded on the American Stock Exchange (AMEX) under the symbol RGN. We are headquartered in Bethesda, Maryland.RegeneRx utilizes an outsourcing business model in order to effectively control costs while focusing on clinical development of our drug candidates. We use this model for research and development, manufacturing, drug formulation and clinical trials, as well as for other functions critical to our mission. We believe this approach enhances our ability to allocate resources rapidly to different projects without having to invest in infrastructure.

Location

3 Bethesda Metro Center
Suite 630
Bethesda
Maryland
20814
United States of America

Contact

Phone: 301.280.1992
Fax: 301.280.1996
Email: info@RegeneRx.com


News Articles [173 Associated News Articles listed on BioPortfolio]

NGM Biopharmaceuticals files for IPO

NGM Biopharmaceuticals Inc. filed for its initial public offering on the Nasdaq.

Transgene and Tasly Biopharmaceuticals Conclude Strategic Agreements for the Rights of Transgene's Virus-Based Immunotherapies TG6002 and TG1050 in Greater China

Transgene to receive $48 million paid in newly created Tasly Biopharmaceuticals shares Deals give Tasly Biopharmaceuticals full control over Greater China1 development and commercial rights to the...

RegeneRx Biopharmaceuticals Inc RGRX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummaryRegeneRx Biopharmaceuticals Inc RegeneRx is a clinicalstage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The com...

RegeneRx Biopharmaceuticals Inc RGRX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryRegeneRx Biopharmaceuticals Inc RegeneRx is a clinicalstage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The com...

RegeneRx Biopharmaceuticals Inc RGRX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryRegeneRx Biopharmaceuticals Inc RegeneRx is a clinicalstage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The com...

Akebia Therapeutics to merge with Keryx Biopharmaceuticals

US-based biopharmaceutical firm Akebia Therapeutics has signed a definitive agreement to merge with Keryx Biopharmaceuticals to form a fully integrated...Read More... The post Akebia Therapeutics to m...

Eiger BioPharmaceuticals completes enrolment in Prevent trial

Eiger BioPharmaceuticals has completed patient enrolment in the Phase ll Prevent trial evaluating the safety and durability of subcutaneous (SC)...Read More... The post Eiger BioPharmaceuticals comple...

Alder BioPharmaceuticals, Inc. (ALDR) to Present at the Canaccord Genuity 38th Annual Growth Conference

Alder BioPharmaceuticals® to Present at the Canaccord Genuity 38th Annual Growth Conference Alder BioPharmaceuticals, Inc. (ALDR), a biopharmaceutical company focused on developing novel therapeutic ...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Thrombin human [Ethicon, Inc]

These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...

PubMed Articles [35 Associated PubMed Articles listed on BioPortfolio]

Acknowledgement to Referees.

Characterisation of protein aggregation with the Smoluchowski coagulation approach for use in biopharmaceuticals.

Protein aggregation is a field of increasing importance in the biopharmaceutical industry. Aggregated particles decrease the effectiveness of the drug and are associated with other risks, such as incr...

Harnessing the power of an expanded genetic code toward next-generation biopharmaceuticals.

Synthetic biology has been revolutionizing the biopharmaceutical industry from drug discovery, clinical development to the manufacturing of biopharmaceuticals. As one of its most promising areas, gene...

Selective N-terminal acylation of peptides and proteins with a Gly-His tag sequence.

Methods for site-selective chemistry on proteins are in high demand for the synthesis of chemically modified biopharmaceuticals, as well as for applications in chemical biology, biosensors and more. I...

Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: a review.

Despite crystallization wide occurrence in pharmaceutical industry, deep understanding and fine control of the process remain tricky issues. Nevertheless, the successful manufacturing of finished phar...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Companies [189 Associated Companies listed on BioPortfolio]

RegeneRx Biopharmaceuticals, Inc. and Lee’s Pharmaceutical Holdings Ltd.

RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration. RegeneRx currently has three drug...

RegeneRx Pharmaceuticals, Inc.

RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration. RegeneRx currently has three drug...

RegeneRx Biopharmaceuticals Inc.

RegeneRx is focused on the discovery and development of novel peptides to accelerate tissue and organ repair. Currently, RegeneRx is developing three product candidates, RGN-13...

RegeneRx Biopharmaceuticals

RegeneRx is a publicly-traded biopharmaceutical company focused on the discovery and development of novel molecules to accelerate tissue and organ repair. Our stock is traded on the American Stock Exc...

RegeneRx Biopharmaceuticals, Inc.

RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tβ4, for tissue and organ protection, repair and regeneration. Currently RegeneRx ...

More Information about "RegeneRx Biopharmaceuticals" on BioPortfolio

We have published hundreds of RegeneRx Biopharmaceuticals news stories on BioPortfolio along with dozens of RegeneRx Biopharmaceuticals Clinical Trials and PubMed Articles about RegeneRx Biopharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RegeneRx Biopharmaceuticals Companies in our database. You can also find out about relevant RegeneRx Biopharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record